NCT03355157 2024-10-01
PADMA
GBG Forschungs GmbH
Phase 4 Completed
Clinical Trials
5 trialsNCT05131841 2021-11-23
Cipterbin Combined With Vinorelbine in the Treatment of HER2-positive MBC
Zhejiang Cancer Hospital
Phase 4 Unknown
NCT03270007 2020-10-28
Research of Intensive Treatment in Hormone Receptor<10% and Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer Patients With Positive Lymph Node Residual Disease After Neoadjuvant Chemotherapy
Peking University
Phase 4 Unknown
NCT01848613 2018-11-09
VIVOS
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 4 Completed
NCT02497118 2015-07-14
Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage â…¢A NSCLC
Tianjin Medical University Cancer Institute and Hospital
Phase 4 Completed